A review about biomarkers for the investigation of vascular function and impairment in diabetes mellitus

被引:21
作者
Derosa, Giuseppe [1 ,2 ]
Maffioli, Pamela [3 ]
机构
[1] Univ Pavia, Dept Internal Med & Therapeut, Ctr Diabet & Metab Dis, Ple C Golgi 2, I-27100 Pavia, Italy
[2] Fdn IRCCS Policlin S Matteo, Ple C Golgi 2, I-27100 Pavia, Italy
[3] Univ Pavia, Sch Expt Med, Pavia, Italy
关键词
biomarkers; vascular function; type 2 diabetes mellitus;
D O I
10.2147/VHRM.S64460
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
The aim of this review was to analyze the main biomarkers of vascular function and impairment in patients with type 2 diabetes. Medline, SCOPUS, Web of Science, and Google Scholar databases were searched. We concluded that proatherogenic adhesion molecules (soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and soluble E selectin) and inflammatory cytokines (high-sensitivity C-reactive protein, interleukin-6, and tumor necrosis factor-alpha) were elevated in type 2 diabetes mellitus. Their increased expression and release contribute to the accelerated atherogenesis typical of these patients. For these reasons, the early identification of high levels of these biomarkers will help to establish new strategies to reduce cardiovascular complications.
引用
收藏
页码:415 / 419
页数:5
相关论文
共 50 条
  • [21] Metabolomics applied to the discovery of tuberculosis and diabetes mellitus biomarkers
    Salgado-Bustamante, Mariana
    Rocha-Viggiano, Ana K.
    Rivas-Santiago, Cesar
    Magana-Aquino, Martin
    Lopez, Jesus A.
    Lopez-Hernandez, Yamile
    BIOMARKERS IN MEDICINE, 2018, 12 (09) : 1001 - 1013
  • [22] The Emerging Role of Biomarkers in the Diagnosis of Gestational Diabetes Mellitus
    Rodrigo, Natassia
    Glastras, Sarah J.
    JOURNAL OF CLINICAL MEDICINE, 2018, 7 (06)
  • [23] Modified lipoproteins as biomarkers of cardiovascular risk in diabetes mellitus
    Luis Sanchez-Quesada, Jose
    Perez, Antonio
    ENDOCRINOLOGIA Y NUTRICION, 2013, 60 (09): : 518 - 528
  • [24] Serum biomarkers for predicting microvascular complications of diabetes mellitus
    Wang, Jiajia
    Song, Xiaoyi
    Xia, Ziqiao
    Feng, Shu
    Zhang, Hangfeng
    Xu, Chengjie
    Zhang, Hui
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2024, 24 (08) : 703 - 713
  • [25] Novel Avenues of Drug Discovery and Biomarkers for Diabetes Mellitus
    Maiese, Kenneth
    Chong, Zhao Zhong
    Shang, Yan Chen
    Hou, Jinling
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (02) : 128 - 152
  • [26] Biomarkers: An Important Tool for Diagnosing and Treating Diabetes Mellitus
    Chakraborty, Tulshi
    Gupta, Sumeet
    Saini, Vipin
    Talukdar, Arindam
    INTERNATIONAL JOURNAL OF LIFE SCIENCE AND PHARMA RESEARCH, 2021, 11 (02): : P123 - P129
  • [27] Pre-Eclampsia Biomarkers for Women With Type 1 Diabetes Mellitus: A Comprehensive Review of Recent Literature
    Freimane, Katrina Z.
    Kerrigan, Lauren
    Eastwood, Kelly-Ann
    Watson, Chris J.
    FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, 2022, 10
  • [28] Diagnostic Biomarkers of Microvascular Complications in Children and Adolescents with Type 1 Diabetes Mellitus-An Updated Review
    Alsharairi, Naser A.
    PEDIATRIC REPORTS, 2024, 16 (03): : 763 - 778
  • [29] Using free access bioinformatic tools to identify potential vascular calcification biomarkers in patients with diabetes mellitus type 2
    Andujar-Vera, F.
    Garcia-Fontana, C.
    Lozano-Alonso, S.
    Morales-Santana, S.
    Munoz-Torres, M.
    Garcia-Fontana, B.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2018, 10 (02) : 71 - 80
  • [30] Evaluation of biomarkers for the prediction of pre-eclampsia in women with type 1 diabetes mellitus: A systematic review
    Wotherspoon, Amy C.
    Young, Ian S.
    McCance, David R.
    Holmes, Valerie A.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2016, 30 (05) : 958 - 966